Analysis of Neutrophil Gelatinase-Associated Lipocalin in Type 2 Diabetes Mellitus Patients

Authors

  • Yunita Rapa' Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University/Dr. Wahidin Sudirohusodo Hospital, Makassar
  • Liong Boy Kurniawan Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University/Hasanuddin University Hospital, Makassar
  • Asvin Nurulita Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University/Dr. Wahidin Sudirohusodo Hospital, Makassar
  • Fitriani Mangarengi Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University/Syekh Yusuf Hospital, Gowa

DOI:

https://doi.org/10.24293/ijcpml.v28i2.1807

Keywords:

Type 2 diabetes mellitus, NGAL

Abstract

Neutrophil Gelatinase-Associated Lipocalin (NGAL) is a small protein with a molecular weight of 21 kDa, belongs to the lipocalin protein family and functions as a growth factor and differentiation of various cell types such as renal tubular epithelial cells. This aim of study was to determine the level of NGAL in controlled and uncontrolled type 2 Diabetes Mellitus (DM) patients. This study was a cross sectional study involving 70 type 2 DM patients with 30 patients with controlled type 2 DM and 40 uncontrolled type 2 DM groups. HbA1c, urea, creatinine, and urinalysis data were measured. NGAL level was measured using the ELISA method. The statistical tests used were Chi-Square, unpaired T test, Mann-Whitney test and Spearman test. The test result is significant if the p-value <0.05. NGAL normally found in the circulation will be filtered by the glomerulus and reabsorbed by the epithelial cells of the proximal renal tubule. Increased levels of NGAL can be found 2-6 hours in the blood and urine after injury to the kidneys. Excretion of NGAL in blood occurs when there is damage to the epithelial cells of the proximal tubule of the kidney. There was a significant difference in NGAL levels in the controlled and uncontrolled groups of type 2 DM patients. Positive correlation indicates that the higher the HbA1c and creatinine levels, the higher the NGAL level. There was a significant difference in NGAL levels in the controlled and uncontrolled type 2 DM groups (25.09 ± 6.83 vs 112.54 ± 170.38 ng / mL, with p value <0.001). There was a positive correlation between NGAL and HbA1c levels with p value <0.001, r =0.507 and creatinine levels with p value <0.001, r =0.769. NGAL normally found in the circulation will be filtered by the glomerulus and reabsorbed by the epithelial cells of the proximal renal tubule. Increased levels of NGAL can be found 2-6 hours in the blood and urine after injury to the kidneys. Excretion of NGAL in blood occurs when there is damage to the epithelial cells of the proximal tubule of the kidney. There was a significant difference in NGAL levels in the controlled and uncontrolled groups of type 2 DM patients. Positive correlation indicates that the higher the HbA1c and creatinine levels, the higher the NGAL level.

Downloads

Download data is not yet available.

Author Biographies

Yunita Rapa', Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University/Dr. Wahidin Sudirohusodo Hospital, Makassar

Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University/Dr. Wahidin Sudirohusodo Hospital, Makassar

Liong Boy Kurniawan, Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University/Hasanuddin University Hospital, Makassar

Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University/Hasanuddin University Hospital, Makassar

Asvin Nurulita, Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University/Dr. Wahidin Sudirohusodo Hospital, Makassar

Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University/Dr. Wahidin Sudirohusodo Hospital, Makassar

Fitriani Mangarengi, Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University/Syekh Yusuf Hospital, Gowa

Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University/Syekh Yusuf Hospital, Gowa

References

American Diabetes Association (ADA). Standards of Medical Care In Diabetes 2019; 42(Supplement 1): S1-S2.

American Diabetes Association (ADA). Classification and Diagnosis of Diabetes: Standards of Medical Care In Diabetes. 2019; 42(Supplement 1): S13-S28.

Kementerian kesehatan Republik Indonesia. Hasil utama RISKESDAS. 2018 [cited at March 20, 2020]. Available at: https://www.kemkes.go.id/resources/download/info-terkini/hasil-riskesdas-2018.pdf

International Diabetes Federation. Diabetes and Cardiovascular Disease. Brussels:International Diabetes Federation. 2019; 9: 1–176.

Huang D, Refaat M, Mohammedi K, Jayyousi A, Suwaidi JA, Khalil CA. Macrovascular Complications in Patients with Diabetes and Prediabetes. BioMed Research International. 2017:1-9.

American Diabetes Association (ADA). Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes. 2019; 42(Supplement 1): S124-S138.

Yim J, Kim G, Lee BW, Kang ES, Cha BS, Kim JH, et al. Relationship Between Circulating Netrin-1 Concentration, Impaired Fasting Glucose, and Newly Diagnosed Type 2 Diabetes. Frontiers in Endocrinology. 2018; 9: 691-8.

Lim AKH. Diabetic Nephropathy-Complications and Treatment. International Journal of Nephrology and Renovascular Disease. 2014; 7: 361-391.

Khausik U, Lewis JB. Update on Diabetic Nephropathy: Core Curriculum. American Journal of Kidney Disease. 2018; 71(6): 884-895.

Alicic RZ, Rooney MT, Tuttle KR. Diabetic Kidney Disease: Challenges, Progress, and Possibilities. Glomerular Disease. Clinical Journal of American Society of Nephrology. 2017; 12(12): 2032-2045.

Shen Z, Fang Yi, Xing T, Wang F. Diabetic Nephropathy: From Pathophysiology to Treatment. Journal of Diabetes Research. 2017:1-2.

Ning M, Mao X, Niu Y, Tang B, Shen H. Usefulness and Limitations of Neutrophil Gelatinase-Associated Lipocalin in The Assessment of Kidney Disease. Journal of Laboratory and Precision Medicine. 2018; 3: 1-10.

Tang XY, Zhou JB, Lou FQ, Han YP, Zhao W, Diao ZL, et al. Urine NGAL as an Early Biomarker for Diabetic Kidney Disease: Accumulated Evidance from Observational Studies. Renal Failure. 2019; 41(1):446-454.

Khawaja S, Jafri L, Siddiqui I, Hashmi M, Ghani F. The Utility of Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Marker of Acute Kidney Injury (AKI) in Critically ill Patients. Biomarker Research. 2019;7(4):1-6.

Fodor R, Grigorescu B, Veres M, Orkandea M, Badea J, Hiavathy K, et al. Plasma Neutrophil Gelatinase-Associated Lipocalin (NGAL)-Early Biomarker for Acute Kidney Injury in Criticallly Ill Patients. The Journal of Critical Care Medicine. 2015; 1(40): 154-161.

Corbacioglu SK, Cvik Y, Akinci E, Uznosmanoglu H, Dagar S, Safak T, et al. Value of Plasma Neutrophile Gelatinase-Associated Lipocalin in Distingushing between Acute Kidney Disease (AKI) and Chronic Kidney Disease (CKD). Turkish Journal of Emergency Medicine. 2017; 17:85-88.

Patel ML, Sachan R, Misra R, Kamal R, Shyam R, Sachan P. Prognostic Significance or Urinary NGAL in Chronic Kidney Disease. International Journal of Nephrology and Renovascular Disease. 2015; 8: 139-144.

Seibert FS, Sitz M, Passfall J, Haesner M, Laschinski P, Buhl M, et al. Prognostic Value of Urinary Calprotectin, NGAL and KIM-1 in Chronic Kidney Disease. Kidney and Blood Pressure Research. 2018; 43: 1255-1262.

Kim SY; Jeong TD, Lee W, Chun S, Sunwoo S, Kim SB, et al. Plasma Neutrophil Gelatinase-Associated Lipocalin as a Marker of Tubular Damage in Diabetic Hephropathy. Annals Of Laboratory Medicine. 2018; 38: 524-529.

Wu J; Shao X, Lu K, Zhou J, Ren M, Xie X, et al. Urinary RBP and NGAL Levels are Associated with Nephropathy in Patients with Type 2 Diabetes. Cellular Physiology anda Biochemistry. 2017; 42: 594-602.

Li A, Yi B, Liu Y, Wang J, Dai Q, Huang Y, et al. Urinary NGAL and RBP are Biomarkers of Normoalbuminuric Renal Insufficiency in Type 2 Diabetes Mellitus. Hindawi Journal of Immunology Research. 2019:1-11.

Downloads

Submitted

2020-12-15

Accepted

2022-01-20

Published

2022-06-03

How to Cite

[1]
Rapa’, Y., Kurniawan, L.B., Nurulita, A. and Mangarengi, F. 2022. Analysis of Neutrophil Gelatinase-Associated Lipocalin in Type 2 Diabetes Mellitus Patients. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY. 28, 2 (Jun. 2022), 185–190. DOI:https://doi.org/10.24293/ijcpml.v28i2.1807.

Issue

Section

Articles